MYC and prostate carcinoma: These findings are in line with previous studies reporting that MYC controls EIF4EBP1 by binding its endogenous promoter in colorectal and prostate cancer cells [36, 37], as demonstrated by ChIP, highlighting a general regulation of EIF4EBP1 by MYC family members in cancer cells.